Vicoprofen is a drug owned by Abbvie Inc. It is protected by 2 US drug patents filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Jun 10, 2017. Details of Vicoprofen's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US6348216 | Ibuprofen and narcotic analgesic compositions |
Jun, 2017
(7 years ago) |
Expired
|
| US6599531 | Method of making ibuprofen and narcotic analgesic compositions |
Jun, 2017
(7 years ago) |
Expired
|
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Vicoprofen's patents.
Latest Legal Activities on Vicoprofen's Patents
Given below is the list of recent legal activities going on the following patents of Vicoprofen.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| File Marked Found | 19 Feb, 2016 | US6599531 |
| Correspondence Address Change Critical | 05 Sep, 2007 | US6599531 |
| Recordation of Patent Grant Mailed Critical | 29 Jul, 2003 | US6599531 |
| Patent Issue Date Used in PTA Calculation Critical | 29 Jul, 2003 | US6599531 |
| Issue Notification Mailed Critical | 10 Jul, 2003 | US6599531 |
| Receipt into Pubs | 23 Jun, 2003 | US6599531 |
| Application Is Considered Ready for Issue Critical | 18 Jun, 2003 | US6599531 |
| Receipt into Pubs | 16 Jun, 2003 | US6599531 |
| Workflow - File Sent to Contractor | 02 Apr, 2003 | US6599531 |
| Receipt into Pubs | 28 Mar, 2003 | US6599531 |
US patents provide insights into the exclusivity only within the United States, but Vicoprofen is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Vicoprofen's family patents as well as insights into ongoing legal events on those patents.
Vicoprofen's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Vicoprofen's generic launch date based on the expiry of its last outstanding patent is estimated to be Jun 10, 2017 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Vicoprofen Generic API suppliers:
Hydrocodone Bitartrate; Ibuprofen is the generic name for the brand Vicoprofen. 8 different companies have already filed for the generic of Vicoprofen, with Sun Pharm Inds Inc having the maximum number of approved applications. Check out the entire list of companies who have already received approval for Vicoprofen's generic
How can I launch a generic of Vicoprofen before its drug patent expiration? :
You can seek FDA approval to launch a generic drug before the expiration of Vicoprofen's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the Vicoprofen's sponsor is invalid, unenforceable, or will not be infringed by your generic product.
Given below are the details of the already filed Para IV certificates on Vicoprofen -
| Strength | Submission Date | ANDA(s) Filed | First applicant approval | Last patent expiry | 180 day status |
|---|---|---|---|---|---|
| 2.5 mg/200 mg | 24 Feb, 2006 | 1 | 19 Oct, 2007 | 10 Jun, 2017 | Eligible |
| 7.5 mg/200 mg | |||||
| 10 mg/200 mg | 20 Mar, 2006 | 1 | 06 Nov, 2006 | 10 Jun, 2017 | Eligible |
About Vicoprofen
Vicoprofen is a drug owned by Abbvie Inc. Vicoprofen uses Hydrocodone Bitartrate; Ibuprofen as an active ingredient. Vicoprofen was launched by Abbvie in 1997.
Approval Date:
Vicoprofen was approved by FDA for market use on 23 September, 1997.
Active Ingredient:
Vicoprofen uses Hydrocodone Bitartrate; Ibuprofen as the active ingredient. Check out other Drugs and Companies using Hydrocodone Bitartrate; Ibuprofen ingredient
Dosage:
Vicoprofen is available in tablet form for oral use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| 7.5MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET | Discontinued | ORAL |